Cost-utility and budget impact analyses of gefitinib in second-line treatment for advanced non-small cell lung cancer from Thai payer perspective

2012 ◽  
Vol 8 (1) ◽  
pp. 53-61 ◽  
Author(s):  
Sumitra THONGPRASERT ◽  
Sirana TINMANEE ◽  
Unchalee PERMSUWAN
2019 ◽  
Vol 22 ◽  
pp. S459-S460
Author(s):  
F. Barrón-Barrón ◽  
A.A. Meneses-García ◽  
L.M. Rivera ◽  
J. de la Garza-Salazar ◽  
A.F. Cardona ◽  
...  

2015 ◽  
Vol 18 (7) ◽  
pp. A457-A458 ◽  
Author(s):  
C Graham ◽  
H Knox ◽  
LM Hess ◽  
M Jen ◽  
G Cuyun Carter ◽  
...  

2011 ◽  
Vol 14 (7) ◽  
pp. A446 ◽  
Author(s):  
E.A.V. Santos ◽  
C.T. Buschinelli ◽  
M. Ferracini ◽  
C. Pepe ◽  
M. Estanislao

2012 ◽  
Vol 23 ◽  
pp. ix438-ix439
Author(s):  
J. Zugazagoitia ◽  
J. Puente ◽  
S. Hernandez ◽  
J.L. Gonzalez-Larriba ◽  
J. Sanz ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document